Related Experiment Video

Updated: Aug 3, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.9K

Letter to the Editor relating to Clin Chem Lab Med 2022;60(9):1365-72

Xiang Sun1, Qin Wang1, Qun Shi1

  • 1Department of Clinical Laboratory, Shanghai Fengxian District Hospital of Traditional Chinese Medicine, Shanghai, P.R. China.

Clinical Chemistry and Laboratory Medicine
|September 2, 2022
PubMed
Abstract

No abstract available in PubMed .

Keywords:
hyperprolactinemiamacroprolactinprevalence

More Related Videos

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes05:58

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

4.2K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.0K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.